In 1958, Powell and Slater (1) first described that DCI had beta-adrenergic blocking activity even though it included beta-adrenergic stimulations. Such property was found also in methoxamine besides its alpha-adrenergic stimulant activity (2, 3). In the follow ing decade, many beta-adrenergic blocking agents have been synthesized successively (4-8) and one of them, propranolol was first introduced in the clinical medicine. Since Ahlquist classified alpha and beta-adrenergic receptors, it has been well established that positive chronotropic and inotropic effects and vaso and broncho-dilator actions of cate cholamines are mediated through an interaction between drug and beta-receptor. How ever, it is not gotten clear, whether all beta-adrenergic blocking agents would have the same potency to block beta-adrenergic receptor in different organs.
cervical level. The direct perfusion of the sinus node artery reported by James and Nadeau (11) was modified by the present authors. The details of preparation were described in previous papers (12, 14) , but all experiments were performed under a constant pressure at 100 mmHg. The arrangement of the constant pressure perfusion is shown in Fig. 1 .
Systemic blood pressure was measured from the femoral artery by a pressure trans ducer (Nihon Kohden RP-2). The ECG (II and epicardial leads) was recorded by a Nihon Kohden ME-20-TR with a paper speed of 1.5 cm/sec and the change in heart rate was continuously recorded by a cardiotachograph (Nihon Kohden RT-2) triggered by the R wave of lead II. An initial dose of 500 U/kg of w-heparin extracted from the whale lung and intestinal mucus membrane (13) was given at the beginning of the perfusion and additional doses of 200 U/kg at two-hours intervals. From time to time, blood was trans fused through the femoral vein in order to keep the initial blood pressure. It amounted to 50 to 100 nil per hour.
Drugs used in these experiments were 1-isoprenaline hydrochloride (Sumitomo Chemi cals), dl-dichloroisoprenaline hydrochloride (Eli Lilly, kindly given by Dr. K.K. Chen), dl-methoxamine hydrochloride (Nippon Shinyaku), dl-(2-isopropylamino-l-hydroxyethyl) methanesulfonanilide hydrochloride (MJ 1999 The volume of injected drug solution was 0.01 ml which was administered in a period of 4 seconds by a microinjector, either the "AGLA" made by Burroughs Wellcome Co., England or the "Jintan" made by Jintan Terumo Co., Japan. The injection of 0.01 ml of saline into the sinus node artery never changed the heart rate at all in spite of a slight vasodilation occasionally. Each drug solution was injected by its own microinjector in order to avoid mutual contamination.
RESULTS

1)
The positive chronotropic effect of isoprenaline ( Fig. 2 and Table 1) The sinus rate before administration of drugs was 141+13.8 beats per minute (mean ±S.E.) and perfusing blood flow of the sinus node artery at 100 mm Hg was 1.80±0.26 ml/min. When isoprenaline was injected into the sinus node artery, a various degree of the positive chronotropic effect was observed ( Fig. 2 and Table 1 ). The sinus rate was significantly increased with relatively small doses of 0.001 ,ug to 0.1 ug. A higher dose produced more significant effect on the duration of tachycardia than on the maximum increase. The mean systemic blood pressure was not affected even with 0.3 ug of iso prenaline but the puls pressure was enlarged. Administration of a high dose of isoprenaline more than 0.1 ag into the sinus node artery frequently caused ventricular extrasystoles usually occurred in the recovery course from the maximum heart rate to the control level.
2) Effects of beta-adrenergic blocking agents on the sinoatrial node (Figs. 3, 4 and 5, and Tables 2 and 3) An increasing dose of 0.1, 1 or 10 pg of beta-adrenergic blocking agents was given into the sinus node artery and compared their chronotropic effects. Smaller doses of DCI, I.C.I. 50 172, H 56/28 and LB 46 caused occasionally an acceleration of the sinus rhythm, while higher doses of all these compounds decelerated the sinus rate (Table 2) . A marked deceleration was obtained with 10 ,ug of methoxamine, 1 ug of MJ 1999, FIG. 3 . Effect of beta-adrenergic blocking agents on the sinoatrial node. SBP : systemic blood pressure, PF : perfusion flow and HR : heart rate. A negative chronotropic effect was shown in these doses of beta-blocking agents. It is worthy to note that the blood flow of the sinus node artery was not affected. (Fig. 3) . Maximum decelerating effects of these compounds were tabulated in per cent to the initial heart rate ( Table  3) . There was no significant difference in the deceleration of the sinus rate among 10 ug of methoxamine and 1 ug of DCI, MJ 1999, I.C.I. 50 172, H 56/28, propranolol and LB 46. When one of these beta-adrenergic blocking agents was administered into the sinus node artery, the sinus arrhythmia was often observed either in the inductory phase to the maximum deceleration or in the recovery course to the initial rhythm. A typical FiG. 5 . AV nodal rhythm induced by H 56/28 which was returned to sinus rhythm by noradrenaline. SBP : systemic blood pressure and HR : heart rate. The ECG of lead II showed shortening of P-Q interval and finally A-V nodal rhythm (B). The P wave reappeared by injection of noradrenaline in the same route (C). experiment is shown in Fig. 4 . In a higher dose of these compounds, the atrioventricular nodal escape rhythm often took place, but it returned to the regular sinus rhythm by in jection of noradrenaline into the sinus node artery (Fig. 5) . When 1 ag of d-, 1 or dl-H 56/28 was injected into the sinus node artery, negative chronotropic effect was induced in the same degree (Fig. 6) , even though d-isomer had no beta-adrenergic blocking activity. systemic blood pressure, PF : perfusion flow and HR : heart rate. These isomers dece lerated the sinus rate almost in the same grade. 3) Antagonism of beta-adrenergic blocking agents against isoprenaline (Figs. 7 and 8, and  Tables 4 and 5) The dose of antagonist was 1 pg, except 10 pg of methoxamine.
Increasing doses of isoprenaline used as an agonist were given before, one, ten and 20 minutes after adminis tration of antagonist into the sinus node artery as shown in Fig. 7 . Time courses of decay of blocking activity against 0.01 ag of isoprenaline were tabulated in Table 4 . The block ing activity was the most potent one minute after administration of a beta-adrenergic block ing agent. Effects of LB 46, propranolol and H 56/28 were longer than those of I.C.I. 50 172 and DCI, while effects of MJ 1999 and methoxamine were significantly short. Results were tabulated in Table 5 and depicted in Fig. 8 , while degrees of blockade in per cent were calculated by a formula inserted in the upper part of the figure. At the antago nist/agonist ratio of 100, the order of adrenergic blocking activity was LB 46> H 56/28 or propranolol>I.C.I. 50 172 or DCI>MJ 1999 methoxamine roughly corresponding to the ratio 1, 2/3, 1/35 1/30 and 1/100. The positive chronotropic effect of isoprenaline was almost completely blocked at the antagonist/agonist ratio of 300 by LB 46, H 56/28 and propranolol.
DISCUSSION
Recently, Blinks (14) evaluated cardiac effect of several beta-adrenergic blocking agents, using isolated guinea-pig atria. Previously the authors arranged the constant pressure perfusion of the sinus node artery in situ in vagotomized dogs (12) . This proce dure in combination with the use of a micrometer-injector permitted us to observe drug response without interference from the chronotropic response to the pressure change caused by injection volume of drug solution.
When naturally occurring catecholamine (dopamine, noradrenaline or adrenaline) was injected into the sinus node artery, the negative chronotropic effect was occasionally observed but isoprenaline never induced such a paradoxical response. Thus isoprenaline must be used as an agonist for evaluation of beta-adrenergic activity. The paradoxical response induced by naturally occurring catecholamines is of cholinergic nature, but it is induced by alpha-adrenergic activity, because phenoxybenzamine prevents the para doxical response (14) .
When a small dose of DCI, LB 46, H 56/28 or I.C.I. 50 172 was injected into the sinus node artery, the heart rate occasionally increased about 30 seconds. This indicates that these beta-adrenergic blocking agents have also sympathomimetic effect (1, 6, 8) . The negative chronotropic effect, however, was induced by a larger dose of all seven drugs. When further increasing dose was given, the sinus arrhythmia was frequently observed and finally the sinus pacemaker was completely depressed. Thus A-V nodal rhythm took place. In this state, an injection of noradrenaline into the sinus node artery, the P wave of ECG reappeared, and the P-Q interval progressively returned to the control level. It was reported that the negative chronotropic effect was not observed in dogs, cardiac nerves of which was chronically denervated (15) and reduced after right stellate ganglion ectomy (4). However d-isomer of H 56/28 had almost no beta-adrenergic blocking effect but it depressed the sinus rate almost in the same grade to 1-isomer, an active beta-adre nergic blocking agent (17) . Thus the cause of sinus bradycardia and sinus arrhythmia which is very similar to the sinus Wenckebach arrhythmia is mainly ascribed to the de pression of pacemaker activity and partly to the blockade of sympathetic tone which may influence the sinus rate. As a matter of fact the sinus Wenckebach arrhythmia was ob served, when propranolol was administered intravenously in the human case (15) .
The negative chronotropic effects of 10 ag of methoxamine and 1 ,ug of other adre nergic beta-receptor blocking activity was LB 46> H 56/28 or propranolol> I.C.I. 50 172 or DCI>MJ 1999>methoxamine roughly in a following rate of 1, 2/3, 1/3, 1/30 and 1/100 respectively. Recently the selectivity of some beta-adrenergic blocking agents was reported. Especially I.C.I. 50 172 had no beta-adrenergic blocking action in the peri pheral vascular system (8). Hashimoto et al. (18) in our laboratories examined beta adrenergic blocking activity of these compounds in the femoral vasculature of dogs, while isoprenaline was used as an agonist. They obtained a different rate of blocking potency as following; LB 46> H 56/28>propranolol>MJ 1999=DCI. I.C.I. 50 172 and methox amine exerted no inhibitory effect. The rate of inhibition is roughly 1, 1/3, 1 / 10 and 1 / 100. Thus LB 46 was the most potent beta-adrenergic blocking agent in both chronotropic and vascular effects in dogs. It is worthy to note that the positive chronotropic response to isoprenaline is completely blocked when sufficient amount of these compounds is given.
On the other hand the vasodilator response to isoprenaline is not completely blocked only by 80 per cent even when sufficient amount of LB 46, the most potent compound, is used.
Furthermore, some differences of blocking activity may be found even among some cardiac functions such as pacemaker activity, conduction velocity, contractile force and cardiac metabolism. Further study is neccessary to clarify this important question.
SUMMARY
Using constant pressure perfusion of the canine sinus node artery, direct action and blocking effect of seven beta-adrenergic blocking agents, i.e., DCI, methoxamine, MJ 1999, propranolol, H 56/28, LB 46 and I.C.I. 50 172 on the sinoatrial node were compared. A depression of sinoatrial pacemaker activity was observed with above 1 ag of these beta adrenergic blocking agents except above 10 "g of methoxamine, while DCI, H 56/28, LB 46 and I.C.I. 50 172 with a smaller dose of 0.1 ag caused occasionally an acceleration of the sinus rhythm. The potency of beta-adrenergic blocking agents decreased in the order; LB 46> H 56/28 or propranolol> I.C.I. 50 172 or DCI MJ 1999 methoxamine, roughly corresponding to the ratio of 1, 2/3, 1/3, 1/30 and 1/100 respectively. It is worthy to note that the positive chronotropic response to isoprenaline is completely blocked by these compounds when sufficient amount is used, while the vasodilator response of the femoral artery to isoprenaline is blocked only 80 per cent.
